Dehydrated pork manure by-product: effect of a chitosan amendment on bacterial community and common scab incidence

Chitosan amendment modified the composition of a microbial community associated with dehydrated pork manure by-product. The amended product (biosolid PC) contained a lower number of anaerobic bacteria than the non-amended product (biosolid P). Chitosan also significantly reduced the fungal population. A 16S rRNA gene bank constructed from DNA extracted from the bacterial community associated with both P and PC biosolids revealed that bacterial orders Xanthomonodales, Pseudomonadales, Enterobacteriales, Burkholderiales, Actinomycetales, Bacillales, Clostridiales and Lactobacillales were found in both biosolids. Bacteria from the Stenotrophomonas genus were abundant in both biosolids. However, the addition of chitosan appeared to induce changes in the population of some bacterial genera. For example, clones carrying a 16S rRNA gene corresponding to the Bacillus genus were doubled in biosolid PC. In field trials carried out to test their effect on common scab incidence, biosolids P and PC were applied as potato seed treatment. Biosolid P increased disease incidence by a factor of 1.33 and 2.85 in two independent experiments. However, when chitosan was added to the seed treatment, the stimulating effect of biosolid P on common scab was cancelled out.Un amendement en chitosane a modifié la composition de la communauté microbienne associée à un sous-produit déshydraté de fumier de porc. Le produit amendé (biosolide PC) contenait un nombre de bactéries anaérobies inférieur à celui du produit non amendé (biosolide P). Le chitosane a aussi réduit de façon significative la population fongique. Une banque de gènes de l’ARNr 16S construite à partir de l’ADN extrait de la communauté bactérienne associée aux biosolides P et PC a révélé que les ordres bactériens Xanthomonodales, Pseudomonadales, Enterobacteriales, Burkholderiales, Actinomycetales, Bacillales, Clostridiales et Lactobacillales se trouvaient dans les deux types de biosolides. Les bactéries du genre Stenotrophomonas étaient les plus abondantes dans les deux types de biosolides. L’addition de chitosane a toutefois induit des changements dans la population de quelques genres de bactéries. Par exemple, les clones transportant un gène d’ARNr 16S correspondant au genre Bacillus doublaient dans le biosolide PC. Dans des essais en champs entrepris dans le but de tester leur effet sur l’incidence de la gale commune, les biosolides P et PC ont été appliqués comme traitement des semences de pomme de terre. Le biosolide P a augmenté l’incidence de la maladie par un facteur de 1,33 et de 2,85 dans deux expériences indépendantes. Toutefois, quand le chitosane était ajouté au traitement de semences, l’effet stimulant du biosolide P sur la gale commune était aboli

Acute and two-week effects of Neotame, Stevia Rebaudioside M and sucrose-sweetened biscuits on postprandial appetite and endocrine response in adults with overweight/obesity – a randomised crossover trial from the SWEET Consortium.

BackgroundSweeteners and sweetness enhancers (S&SE) are used to replace energy yielding sugars and maintain sweet taste in a wide range of products, but controversy exists about their effects on appetite and endocrine responses in reduced or no added sugar solid foods. The aim of the current study was to evaluate the acute (1 day) and repeated (two-week daily) ingestive effects of 2 S&SE vs. sucrose formulations of biscuit with fruit filling on appetite and endocrine responses in adults with overweight and obesity.MethodsIn a randomised crossover trial, 53 healthy adults (33 female, 20 male) with overweight/obesity in England and France consumed biscuits with fruit filling containing 1) sucrose, or reformulated with either 2) Stevia Rebaudioside M (StRebM) or 3) Neotame daily during three, two-week intervention periods with a two-week washout. The primary outcome was composite appetite score defined as [desire to eat + hunger + (100 - fullness) + prospective consumption]/4.FindingsEach formulation elicited a similar reduction in appetite sensations (3-h postprandial net iAUC). Postprandial insulin (2-h iAUC) was lower after Neotame (95% CI (0.093, 0.166); p InterpretationIn conclusion, biscuits reformulated to replace sugar using StRebM or Neotame showed no differences in appetite or endocrine responses, acutely or after a two-week exposure, but can reduce postprandial insulin and glucose response in adults with overweight or obesity.FundingThe present study was funded by the Horizon 2020 program: Sweeteners and sweetness enhancers: Impact on health, obesity, safety and sustainability (acronym: SWEET, grant no: 774293)

Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease

Inherited retinal disease is a common cause of visual impairment and represents a highly heterogeneous group of conditions. Here, we present findings from a cohort of 722 individuals with inherited retinal disease, who have had whole-genome sequencing (n = 605), whole-exome sequencing (n = 72), or both (n = 45) performed, as part of the NIHR-BioResource Rare Diseases research study. We identified pathogenic variants (single-nucleotide variants, indels, or structural variants) for 404/722 (56%) individuals. Whole-genome sequencing gives unprecedented power to detect three categories of pathogenic variants in particular: structural variants, variants in GC-rich regions, which have significantly improved coverage compared to whole-exome sequencing, and variants in non-coding regulatory regions. In addition to previously reported pathogenic regulatory variants, we have identified a previously unreported pathogenic intronic variant in $\textit{CHM}$ in two males with choroideremia. We have also identified 19 genes not previously known to be associated with inherited retinal disease, which harbor biallelic predicted protein-truncating variants in unsolved cases. Whole-genome sequencing is an increasingly important comprehensive method with which to investigate the genetic causes of inherited retinal disease.This work was supported by The National Institute for Health Research England (NIHR) for the NIHR BioResource – Rare Diseases project (grant number RG65966). The Moorfields Eye Hospital cohort of patients and clinical and imaging data were ascertained and collected with the support of grants from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital, National Health Service Foundation Trust, and UCL Institute of Ophthalmology, Moorfields Eye Hospital Special Trustees, Moorfields Eye Charity, the Foundation Fighting Blindness (USA), and Retinitis Pigmentosa Fighting Blindness. M.M. is a recipient of an FFB Career Development Award. E.M. is supported by UCLH/UCL NIHR Biomedical Research Centre. F.L.R. and D.G. are supported by Cambridge NIHR Biomedical Research Centre

The James Webb Space Telescope Mission

Twenty-six years ago a small committee report, building on earlier studies, expounded a compelling and poetic vision for the future of astronomy, calling for an infrared-optimized space telescope with an aperture of at least $4m$. With the support of their governments in the US, Europe, and Canada, 20,000 people realized that vision as the $6.5m$ James Webb Space Telescope. A generation of astronomers will celebrate their accomplishments for the life of the mission, potentially as long as 20 years, and beyond. This report and the scientific discoveries that follow are extended thank-you notes to the 20,000 team members. The telescope is working perfectly, with much better image quality than expected. In this and accompanying papers, we give a brief history, describe the observatory, outline its objectives and current observing program, and discuss the inventions and people who made it possible. We cite detailed reports on the design and the measured performance on orbit.Comment: Accepted by PASP for the special issue on The James Webb Space Telescope Overview, 29 pages, 4 figure

The Impact of a Cognitive-Behavioral Therapy on Event-Related Potentials in Patients with Tic Disorders or Body-Focused Repetitive Behaviors

Context: Tic disorders (TD) are characterized by the presence of non-voluntary contractions of functionally related groups of skeletal muscles in one or multiple body parts. Patients with body-focused repetitive behaviors (BFRB) present frequent and repetitive behaviors, such as nail biting or hair pulling. TD and BFRB can be treated with a cognitive-behavioral therapy (CBT) that regulates the excessive amount of sensorimotor activation and muscular tension. Our CBT, which is called the cognitive-psychophysiological therapy (CoPs), targets motor execution and inhibition, and it was reported to modify brain activity in TD. However, psychophysiological effects of therapy are still poorly understood in TD and BFRB patients. Our goals were to compare the event-related potentials (ERP) of TD and BFRB patients to control participants, and to investigate the effects of the CoPs therapy on the P200, N200 and P300 components during a motor and non-motor oddball task.Method: ERP components were compared in 26 TD patients, 27 BFRB patients and 27 control participants. ERP were obtained from 63 EEG electrodes during two oddball tasks. In the non-motor task, participants had to count rare stimuli. In the motor task, participants had to respond with a left or right button press for rare and frequent stimuli, respectively. ERP measures were recorded before and after therapy in both patients groups.Results: CoPs therapy improved symptoms similarly in both clinical groups. Before therapy, TD and BFRB patients had lower P300 oddball effect during the non-motor task, in comparison with controls participants. An increase in the P300 oddball effect was observed post therapy. This increase was distributed over the whole cortex in BFRB patients, but localized in the parietal area in TD patients.Discussion: These results suggest a modification of neural processes following CoPs therapy in TD and BFRB patients. CoPs therapy seems to impact patients’ attentional processes and context updating capacities in working memory (i.e. P300 component). Our results are consistent with a possible role of the prefrontal cortex and corpus callosum in mediating inter-hemispheric interference in TD

Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice

Lithium is the first-line therapy for bipolar disorder. However, its therapeutic target remains controversial. Candidates include inositol monophosphatases, glycogen synthase kinase-3 (GSK-3), and a β-arrestin-2/AKT/protein phosphatase 2A (β-arrestin-2/AKT/PP2A) complex that is known to be required for lithium-sensitive behaviors. Defining the direct target(s) is critical for the development of new therapies and for elucidating the molecular pathogenesis of this major psychiatric disorder. Here, we show what we believe to be a new link between GSK-3 and the β-arrestin-2 complex in mice and propose an integrated mechanism that accounts for the effects of lithium on multiple behaviors. GSK-3β (Gsk3b) overexpression reversed behavioral defects observed in lithium-treated mice and similar behaviors observed in Gsk3b+/– mice. Furthermore, immunoprecipitation of striatial tissue from WT mice revealed that lithium disrupted the β-arrestin-2/Akt/PP2A complex by directly inhibiting GSK-3. GSK-3 inhibitors or loss of one copy of the Gsk3b gene reduced β-arrestin-2/Akt/PP2A complex formation in mice, while overexpression of Gsk3b restored complex formation in lithium-treated mice. Thus, GSK-3 regulates the stability of the β-arrestin-2/Akt/PP2A complex, and lithium disrupts the complex through direct inhibition of GSK-3. We believe these findings reveal a new role for GSK-3 within the β-arrestin complex and demonstrate that GSK-3 is a critical target of lithium in mammalian behaviors